New research reveals that non-fasting triglyceride (TG) levels are stronger predictors of cardiovascular disease (CVD) risk than fasting TG levels—especially in people with abdominal obesity.
🔍 Key Takeaways:
✅ Non-fasting TG levels better reflect post-meal lipid metabolism and are more strongly linked to heart disease risk.
✅ Current guidelines prioritize fasting lipid profiles, which may underestimate CVD risk in individuals with abdominal obesity.
✅ Abdominal fat has a greater impact on non-fasting TG levels, highlighting its role in heart health.
💡 Clinical Takeaway:
It’s time to rethink lipid testing! Non-fasting TG levels should be considered in routine assessments to better identify high-risk individuals.
Christiansen, M. R., Romero-Lado, M. J., Carrasquilla, G. D., & Kilpeläinen, T. O. (2025). The differential impact of abdominal obesity on fasting and non-fasting triglycerides and cardiovascular risk. European Journal of Preventive Cardiology. https://doi.org/10.1093/eurjpc/zwaf058
Comments